Bekky Feltham
Dr Rebecca Feltham is a ubiquitin molecular cell biologist whose lab at WEHI is dedicated to cracking the code of E3 ligases. She leads the E3-ome project, the most complete catalogue of human E3 ligases, and is co-founder of the degrader biotech Ternarx. Her group explores E3 ligases as drug targets in cancer and inflammation, developing next-generation degrader technologies to turn previously “undruggable” proteins into therapeutic opportunities.
Abstracts this author is presenting:
